HMGCS2 and neoplasm: Various assays conducted in different renal clear cell carcinoma cell lines consistently demonstrated that loss or ectopic expression of HMGCS2 alters proliferation, cell cycle, and apoptosis in renal clear cell carcinoma, exerting tumor-suppressive effects while inhibiting glycolysis in OSRC2 cells.